Selz Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-559,000
Closed -$8.35M 64
2019
Q3
$8.35M Sell
559,000
-60,000
-10% -$976K 2.1% 16
2019
Q2
$14.9M Buy
619,000
+163,100
+36% +$4.81M 4.01% 8
2019
Q1
$16.9M Sell
455,900
-85,000
-16% -$3.09M 3.24% 12
2018
Q4
$15.3M Buy
540,900
+236,000
+77% +$7.46M 4.49% 8
2018
Q3
$12M Sell
304,900
-37,000
-11% -$1.62M 2.65% 14
2018
Q2
$15.2M Buy
341,900
+80,000
+31% +$3.98M 2.39% 19
2018
Q1
$12.8M Buy
261,900
+200,900
+329% +$10M 1.97% 22
2017
Q4
$3.05M Sell
61,000
-30,000
-33% -$1.57M 0.45% 42
2017
Q3
$4.61M Hold
91,000
0.92% 30
2017
Q2
$3.45M Buy
+91,000
New +$3.59M 0.97% 24

Other funds holding CC

Selz Capital's CC Position: Q4 2019 in Review

Selz Capital sold out of Chemours (CC) in Q4 2019, closing a stake of 559,000 shares — an estimated $8.35M sold.

Selz Capital first reported a position in CC in Q2 2017 and held it in 10 quarters. The position peaked at $16.9M in Q1 2019. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

  • Selz Capital reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
  • Selz Capital sold 559,000 Chemours shares in Q4 2019, an estimated $8.35M.
  • Selz Capital first reported a position in Chemours in Q2 2017 and held it in 10 quarters.
  • Selz Capital's Chemours position peaked at $16.9M in Q1 2019.
  • 439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Selz Capital's 13F filing for Q4 2019, filed 16 Jan 2020.